Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Theophylline for Biomass-Associated COPD
NCT03984188Phase 3Completed
- Sponsor
- University of Miami
- Start
- Feb 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Low-dose Theophylline Group with Placebo Group (2 arms). Primary endpoint: St. George Respiratory Questionnaire at 1 year. Started Feb 2021; status: completed.
02
Drugs
theophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03984188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03984188.